Incyte And Syndax : FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes
16/1 01:57
(RTTNews) - Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that the U.S. Food and Drug Administration has approved Niktimvo (axatilimab-csfr) in 9 mg and 22 mg vial sizes. The Companies expect product to be available for order in the U.S. in early February....